Company News in the Life Science Industry

»

Reset 

Qu Biologics publishes potentially paradigm-shifting results of their first randomized-placebo controlled trial for the treatment of Crohn’s disease

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019

Parents Spent More Time Outdoors in Their Youth Than Children Do Today, Finds New Survey by VELUX Revealing We Are Collectively Spending Less Time in Nature

LONDON, July 23, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 23 Jul 2019

Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group

Supported by comparative Dosisphere data, a phase II multicentric randomised dosimetry trial

Read more ››
By: PR Newswire Association LLC. - 23 Jul 2019

Blighter Reshapes Board for Growth

- Radar firm appoints Keith Todd CBE (former CEO of ICL plc) as non-executive chairman, Angus Hone (former CFO of various technology companies) as CEO, Tracy Sambrook (former CFO of Nutmeg) as CFO, and Carl P. Bannar (former VP of Lockheed Martin Rotary & Mission Systems business) as... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019

SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 23, 2019 /CNW/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial. The PIONEER III trial is designed to assess... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019
Related companies:  Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA)

Key Surgical Signs Agreement To Acquire Insitumed

MINNEAPOLIS, July 23, 2019 /PRNewswire/ -- Key Surgical LLC, a leading global provider of sterile processing and operating theatre... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019

Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation

SEATTLE and VANCOUVER, British Columbia, July 23, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced it has extended its strategic collaboration with the National Center for Complementary and... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019
Related companies:  Achieve Life Sciences,Inc.

Anatomic Pathology Market Worth $23.3 Billion by 2025 | CAGR 6.1%: Grand View Research, Inc.

SAN FRANCISCO, July 23, 2019 /PRNewswire/ -- The global anatomic... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019

Stero Biotechs to Commence Phase 2a Clinical Trial of Cannabidiol-Based Formulation for Patients With Crohn's Disease

TEL AVIV, Israel, July 23, 2019 /PRNewswire/ -- Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized,... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019

People Are More Likely to Try Drugs for the First Time During the Summer

NEW YORK, July 23, 2019 /PRNewswire/ -- American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Read more ››
By: PR Newswire Association LLC. - 23 Jul 2019
Related companies:  NYU Langone Health | NYU Langone Medical Center- Cytometry & Cell Sorting Laboratory

University of California granted two new U.S. CRISPR-Cas9 patents

BERKELEY, Calif., July 23, 2019 /PRNewswire/ -- Today, the U.S. Patent and Trademark Office has awarded two new patents to the University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of the CRISPR-Cas9 gene-editing technology.

Read more ››
By: PR Newswire Association LLC. - 23 Jul 2019

Ablative Solutions Announces Enrollment and Randomization of First Patient in Global Clinical Trial Evaluating Company's Novel Therapy for Uncontrolled Hypertension

SAN JOSE, Calif., July 23, 2019 /PRNewswire/ -- Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the enrollment and randomization of the first patient in the TARGET BP I global clinical trial. Piedmont Heart Institute in Atlanta is... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019
Related companies:  Ablative Solutions, Inc.

Idorsia announces financial results for the first half of 2019

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019
Related companies:  Idorsia Pharmaceuticals Ltd

Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu® in Flu Care

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jul 2019

Biofeedback Therapeutic Wearable for People With ADHD

ST. PETERSBURG, Fla., July 22, 2019 /PRNewswire/ -- Our Mission

Read more ››
By: PR Newswire Association LLC. - 23 Jul 2019

InvestAcure Honors 10 Leading Scientists With the Cure Coin Award for Work Developing Alzheimer's Diagnostics and Treatments

NEW YORK, July 22, 2019 /PRNewswire/ -- InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their... Read more ››

By: PR Newswire Association LLC. - 23 Jul 2019

Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Cytokinetics, Inc.

Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Forty Seven Inc.

Myovant Sciences to Host Webcast and Conference Call at 8:30 a.m. Eastern Time Tuesday, July 23rd to Discuss Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids and from Bioequivalence

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Myovant Sciences, Inc.

Silk Road Medical to Report Second Quarter 2019 Financial Results on July 29, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jul 2019
Related companies:  Silk Road Medical Inc.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies